Saint Paul, Minn. – An estimated 54 new jobs are coming to the Plymouth from the Minnesota Department of Employment and Economic Development (DEED)-administered Minnesota Job Creation Fund (JCF). Qorvo Biotechnologies of Plymouth is expanding its biotechnology project development and operation with plans to increase the existing footprint by 13,500 square feet. This will help support the growth of its Qorvo Omnia™ Diagnostic Test Platform and COVID Antigen Test, recently authorized by the FDA. DEED is supporting the project with a JCF award of $175,000, and funding will be awarded once the project meets the established criteria.
“Testing remains a critical component to our strategy in slowing the spread of COVID-19 and tracking transmission rates,” said Rep. Ginny Klevorn (DFL-Plymouth). “I’m grateful for investments like the Job Creation Fund so Qorvo Biotechnologies can continue to build innovation, create jobs, and contribute to the science-driven solutions Minnesotans are counting on in combatting the pandemic.”
The Job Creation Fund provides financial incentives to new and expanding businesses that meet certain job creation and capital investment targets. Eligible companies may receive up to $1 million for creating or retaining high-paying jobs and for constructing or renovating facilities or making other property improvements.